Lineage Cell Therapeutics, Inc. (LCTX) SEC Filings — 2024
17 SEC filings for Lineage Cell Therapeutics, Inc. (LCTX) in 2024.
Filings
- Lineage Cell Therapeutics Files Definitive Proxy Statement — DEF 14A · Dec 9, 2024
- Broadwood Partners Amends Lineage Cell Therapeutics Stake — SC 13D/A · Nov 21, 2024
- Lineage Cell Therapeutics Closes $50M Public Offering — 8-K · Nov 20, 2024
- Lineage Cell Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Lineage Cell Therapeutics, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
- Lineage Cell Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
- Lineage Cell Therapeutics Q2 2024 Update — 10-Q · Aug 8, 2024
- Lineage Cell Therapeutics Changes Accountants Amidst Disagreement — 8-K · Jun 14, 2024
- Lineage Cell Therapeutics Files 8-K — 8-K · Jun 13, 2024
- Lineage Cell Therapeutics Files 8-K — 8-K · May 14, 2024
- Lineage Cell Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
- Lineage Cell Therapeutics Announces 2024 Annual Meeting of Shareholders on June 11 — DEF 14A · Apr 29, 2024
- Lineage Cell Therapeutics Closes $50M Public Offering — 8-K · Mar 22, 2024
- Lineage Cell Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Mar 7, 2024
- Lineage Cell Therapeutics Files 'Other Events' 8-K — 8-K · Feb 15, 2024
- Broadwood Partners Cuts Lineage Cell Therapeutics Stake to 24.9% — SC 13D/A · Feb 8, 2024
- Lineage Cell Therapeutics Files 8-K on Material Definitive Agreement — 8-K · Feb 6, 2024